Fundraising Fox

Siren Biotechnology

San Francisco, US · Founded 2020 · 7 known investors

sirenbiotechnology.com ↗

Siren Biotechnology develops next-generation AAV (adeno-associated virus) platforms for gene therapy applications, including gene repair, gene transfer, and gene editing. The company focuses on advancing treatments for a wide range of rare diseases through engineered viral vectors and directed evolution approaches.

BiotechDigital HealthMedical Devicesin /siren-biotechnology-inc@sirenbio

Founders & leadership

DN
Dr. Nicole PaulkCEO, Founder, and President
ST
Sharon TetlowDirector
BA
Brad AllenDirector
NP
Nicole PaulkExecutive Officer, Director

Investors · 7

Artis VenturesSan Francisco · $50K – $25M
AvilaGolden Beach · $500K – $2.5Mvia Patricia Wexler · inferred
Carnrite VenturesHouston
Civilization Ventures Management, LlcTiburon · $1M – $10M
HAWKTAILSan Francisco
NZVCAuckland
Plum Alley InvestmentsNew York · $500K – $1.5M

Reported raises · per SEC filings

Form D private placements
▶$19.6MraisedApr 2024 · 57 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Sharon TetlowDirector
  • Brad AllenDirector
  • Nicole PaulkExecutive Officer, Director
Offering amount
$32.4M
Amount sold
$19.6M
First sale
Apr 2024
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news